Requires health insurance policies to cover comprehensive genetic screening for ovarian and prostate cancers

This bill (A 6475, the "Ana Lucia Act") requires health insurance plans to cover comprehensive genetic screening and FDA-approved biomarker testing for ovarian and prostate cancers. It mandates full coverage - without deductibles or coinsurance - when recommended by a doctor, geneticist, or genetic counselor, for both diagnosed patients and their family members. The law prohibits insurers from using genetic test results to deny coverage to family members who carry inherited mutations. This directly affects patients with ovarian or prostate cancer, their relatives, and health insurers operating under New York's insurance laws. The coverage applies to all policies issued or renewed after the bill takes effect.